In a preliminary study using blood and spinal fluid samples from 200 people, Johns Hopkins Medicine researchers say they have evidence that a well-studied protein involved in blood pressure regulation may serve as a marker for—and perhaps play a role in—treatment-resistant schizophrenia and other psychoses.